Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 957-963

  Kohno, Takashi ^a   Kunitoh, Hideo ^b   Suzuki, Kenji ^c   Yamamoto, Seiichiro ^d   Kuchiba, Aya ^d,e   Matsuno, Yoshihiro ^c,g   Yanagitani, Noriko ^a,f   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Thoracic Oncology Division   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f GUNMA UNIVERSITY   (Japan)

^g HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ARGININE; CYTOSINE; GUANINE; K RAS PROTEIN; LYMPHOID RESTRICTED MEMBRANE PROTEIN; MEMBRANE PROTEIN; ONCOPROTEIN; SERINE; TUMOR SUSCEPTIBILITY CANDIDATE 1 PROTEIN; TYROSINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMATOSIS, PULMONARY; AGED; ANTIGENS, NEOPLASM; ANTIGENS, NUCLEAR; DNA, NEOPLASM; FEMALE; HUMANS; HYPERPLASIA; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RISK FACTORS; SMOKING;

EID: 47249144759     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn048     Document Type: Article

References (37)

1. Parkin,M. et al. (2004) Lung cancer epidemiology and etiology. In Travis,W.D., Brambilla,E., Muller-Hermelink,H.K. and Harris,C.C. (eds) World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. IARC Press, Lyon, pp. 31-34.
2. Colvy,T. et al. (2004) Adenocarcinoma. In Travis,W.D., Brambilla,E., Muller-Hermelink,H.K. and Harris,C.C. (eds) World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. IARC Press, Lyon, pp. 35-44.
3. Nakachi,K. et al. (1995) Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis, 16, 2209-2213.
4. Sunaga,N. et al. (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol. Biomarkers Prev., 11, 730-738.
5. Larsen,J.E. et al. (2006) CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27, 525-532.
6. Kohno,T. et al. (2006) Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci., 97, 724-728.
7. Malkinson,A.M. (1989) The genetic basis of susceptibility to lung tumors in mice. Toxicology, 54, 241-271.
8. Gariboldi,M. et al. (1993) A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet., 3, 132-136.
9. Fijneman,R.J. et al. (1996) Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14 465-467.
10. Manenti,G. et al. (1996) Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Nat. Genet., 12, 455-457.
11. Manenti,G. et al. (2003) Outbred CD-1 mice carry the susceptibility allele at the pulmonary adenoma susceptibility 1 (Pas1) locus. Carcinogenesis, 24, 1143-1148.
12. Balmain,A. et al. (1998) Cancer resistance genes in mice: Models for the study of tumour modifiers. Trends Genet., 14, 139-144.
13. Sakiyama,T. et al. (2005) Association of amino acid substitution polymorphisms in DNA repair genes TP53, POL1, REV1 and LIG4 with lung cancer risk. Int. J. Cancer, 114, 730-737.
14. Maria,D.A. et al. (2003) Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Oncogene, 22, 426-432.
15. Zhang,Z. et al. (2003) Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice. Proc. Natl Acad. Sci. USA, 100, 12642-12647.
16. Manenti,G. et al. (2004) Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene, 23 4495-4504.
17. Liu,P. et al. (2006) Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat. Genet., 38, 888-895.
18. To,M.D. et al. (2006) A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat. Genet., 38, 926-930.
19. Manenti,G. et al. (1997) Association of chromosome 12p genetic polymorphism with lung adenocarcinoma risk and prognosis. Carcinogenesis, 18, 1917-1920.
20. Dragani,T.A. et al. (2000) Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res., 60, 5017-5020.
21. Manenti,G. et al. (2000) Predisposition to lung tumorigenesis. Toxicol. Lett., 112-113, 257-263.
22. Manenti,G. et al. (2006) A V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients. Carcinogenesis, 27, 1386-1390.
23. Niho,S. et al. (1999) Monoclonality of atypical adenomatous hyperplasia of the lung. Am. J. Pathol., 154, 249-254.
24. Kerr,K.M. et al. (2004) Atypical adenomatous hyperplasia. In Travis,W.D., Brambilla,E., Muller-Hermelink,H.K. and Harris,C.C. (eds) World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. IARC Press, Lyon, pp. 73-75.
25. Koga,T. et al. (2002) Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia. Am. J. Clin. Pathol., 117, 464-470.
26. Sterner,D.J. et al. (1997) Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: A study of 100 cases. Mod. Pathol., 10, 469-473.
27. Yokose,T. et al. (2000) High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer, 29, 125-130.
28. Yokose,T. et al. (2001) Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer, 33, 155-161.
29. Brambilla,E. et al. (2001) The new World Health Organization classification of lung tumours. Eur. Respir. J., 18, 1059-1068.
30. Travis,W., Colby,T.V., Corrin,B., Shimosato,Y. and Brambilla,E. (eds) 1999 Histological Typing of Lung and Pleural Tumors. Springer-Verlag, Heidelberg, Germany.
31. Breslow,N.E. et al. (1980) Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci. Publ., 32, 5-338.
32. Karasaki,H. et al. (1997) Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: Differential effects on tumor multiplicity, size and Kras2 mutations. Oncogene, 15 1833-1840.
33. Lin,L. et al. (1998) Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res., 24, 481-497.
34. Shigematsu,H. et al. (2006) Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int. J. Cancer, 118, 257-262.
35. Westra,W.H. et al. (1996) K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res., 56, 2224-2228.
36. Manenti,G. et al. (1998) Genetic mapping of cancer susceptibility/ resistance loci in the mouse. Recent Results Cancer Res., 154 292-297.
37. Wang,M. et al. (2003) Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res., 63, 3317-3324.